StonvexLoading…
StonvexStonvexStonvexCore line items from CTRN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2026 2026-01-31 | Annual 2025 2025-02-01 | Annual 2024 2024-02-03 | Annual 2023 2023-01-28 |
|---|---|---|---|---|
Revenue | $819.96M | $753.08M | $747.94M | $795.01M |
Operating Income | $3.85M | $-39.49M | $-19.45M | $75.31M |
Net Income | $5.21M | $-43.17M | $-11.98M | $58.89M |
EPS (Diluted) | $0.63 | $-5.19 | $-1.46 | $7.17 |
Total Assets | $471.17M | $462.77M | $518.72M | $544.26M |
Total Liabilities | $354.85M | $349.59M | $361.01M | $377.81M |
Cash & Equivalents | $66.09M | $61.09M | $79.71M | $103.50M |
Free Cash Flow OCF − CapEx | $624.00K | $-13.96M | $-24.45M | $-16.53M |
Shares Outstanding | 8.35M | 8.55M | 8.55M | 8.35M |